These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8029495)

  • 21. The role of CYP forms in the metabolism and metabolic activation of HCFCs and other halocarbons.
    White IN; De Matteis F
    Toxicol Lett; 2001 Oct; 124(1-3):121-8. PubMed ID: 11684364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trifluoroacetylated proteins in liver and plasma of guinea pigs treated with HCFC-123 and halothane.
    Bortolato S; Zanovello A; Rugge M; Brotto M; Marini S; Gervasi PG; Manno M
    Toxicol Lett; 2003 Sep; 144(1):35-47. PubMed ID: 12919722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,1,1-Trifluoro-2,2-dichloroethane (HCFC-123) and 1,1,1-trifluoro-2-bromo-2-chloroethane (halothane) cause similar biochemical effects in rats exposed by inhalation for five days.
    Keller DA; Lieder PH; Brock WJ; Cook JC
    Drug Chem Toxicol; 1998 Nov; 21(4):405-15. PubMed ID: 9839153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional modeling of HCFC-123 in the atmosphere: assessing its potential environmental impacts and rationale for continued use.
    Wuebbles DJ; Patten KO
    Environ Sci Technol; 2009 May; 43(9):3208-13. PubMed ID: 19534136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatotoxicity in guinea pigs following acute inhalation exposure to 1,1-dichloro-2,2,2-trifluoroethane.
    Marit GB; Dodd DE; George ME; Vinegar A
    Toxicol Pathol; 1994; 22(4):404-14. PubMed ID: 7817129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CFC to HFA transition and its impact on pulmonary drug development.
    Leach CL
    Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a sampling and analytical method for 2,2-dichloro-1,1,1-trifluoroethane in workplace air.
    Shin YC; Yi GY; Kim Y; Paik NW
    AIHA J (Fairfax, Va); 2002; 63(6):715-20. PubMed ID: 12570079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Turning CFCs into salt.
    Environ Health Perspect; 1996 May; 104(5):468-9. PubMed ID: 8743429
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of ozone-depleting substances; removal of essential-use designations. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Apr; 70(63):17167-92. PubMed ID: 15806739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute liver dysfunction among workers exposed to 2,2-dichloro-1,1,1-tryfluoroethane (HCFC-123): a case report.
    Takebayashi T; Kabe I; Endo Y; Tanaka S; Miyauchi H; Nozi K; Takahashi K; Omae K
    Appl Occup Environ Hyg; 1999 Feb; 14(2):72-4. PubMed ID: 10457632
    [No Abstract]   [Full Text] [Related]  

  • 32. CFCS and the ozone layer.
    Hayman GD
    Br J Clin Pract Suppl; 1997 May; 89():2-9. PubMed ID: 9519506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of the hydrochlorofluorocarbon 1,2-dichloro-1,1-difluoroethane.
    Harris JW; Anders MW
    Chem Res Toxicol; 1991; 4(2):180-6. PubMed ID: 1782346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioactivation to free radicals and cytotoxicity of 1,1-dichloro-1-fluoroethane (HCFC-141b).
    Zanovello A; Tolando R; Ferrara R; Bortolato S; Manno M
    Xenobiotica; 2001 Feb; 31(2):99-112. PubMed ID: 11407538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhalation teratology and reproduction studies with 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123).
    Malinverno G; Rusch GM; Millischer RJ; Hughes EW; Schroeder RE; Coombs DW
    Fundam Appl Toxicol; 1996 Dec; 34(2):276-87. PubMed ID: 8954757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exposure to the chlorofluorocarbon substitute 2,2-dichloro-1,1,1- trifluoroethane and the anesthetic agent halothane is associated with transient protein adduct formation in the heart.
    Huwyler J; Gut J
    Biochem Biophys Res Commun; 1992 May; 184(3):1344-9. PubMed ID: 1590796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123).
    Loizou GD; Urban G; Dekant W; Anders MW
    Drug Metab Dispos; 1994; 22(4):511-7. PubMed ID: 7956723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economics of "essential use exemptions" for metered-dose inhalers under the Montreal Protocol.
    DeCanio SJ; Norman CS
    J Environ Manage; 2007 Oct; 85(1):1-8. PubMed ID: 16982135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stratospheric ozone, global warming, and the principle of unintended consequences--an ongoing science and policy success story.
    Andersen SO; Halberstadt ML; Borgford-Parnell N
    J Air Waste Manag Assoc; 2013 Jun; 63(6):607-47. PubMed ID: 23858990
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.